Biocon Plans July Launch Of India's First-Of-Class Psoriasis Drug
This article was originally published in PharmAsia News
Executive Summary
India is about to get its first drug in a new class of biologic treatments, Biocon's Alzumab (itolizumab) for treating chronic plaque psoriasis.